Cargando…
RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645525/ http://dx.doi.org/10.1186/2051-1426-3-S2-P163 |
| _version_ | 1782400832304578560 |
|---|---|
| author | Heidenreich, Regina Mehr, Keyvan Tadjalli Noth, Janine Koch, Sven Hong, Henoch Melber, Karl Daehling, Angelika Roos, Tilmann Lutz, Johannes Kowalczyk, Aleksandra Baumhof, Patrick Scheel, Birgit Voss, Söhnke Kallen, Karl-Josef Fotin-Mleczek, Mariola Gnad-Vogt, Ulrike |
| author_facet | Heidenreich, Regina Mehr, Keyvan Tadjalli Noth, Janine Koch, Sven Hong, Henoch Melber, Karl Daehling, Angelika Roos, Tilmann Lutz, Johannes Kowalczyk, Aleksandra Baumhof, Patrick Scheel, Birgit Voss, Söhnke Kallen, Karl-Josef Fotin-Mleczek, Mariola Gnad-Vogt, Ulrike |
| author_sort | Heidenreich, Regina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645525 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46455252015-11-20 RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile Heidenreich, Regina Mehr, Keyvan Tadjalli Noth, Janine Koch, Sven Hong, Henoch Melber, Karl Daehling, Angelika Roos, Tilmann Lutz, Johannes Kowalczyk, Aleksandra Baumhof, Patrick Scheel, Birgit Voss, Söhnke Kallen, Karl-Josef Fotin-Mleczek, Mariola Gnad-Vogt, Ulrike J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645525/ http://dx.doi.org/10.1186/2051-1426-3-S2-P163 Text en Copyright © 2015 Heidenreich et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Heidenreich, Regina Mehr, Keyvan Tadjalli Noth, Janine Koch, Sven Hong, Henoch Melber, Karl Daehling, Angelika Roos, Tilmann Lutz, Johannes Kowalczyk, Aleksandra Baumhof, Patrick Scheel, Birgit Voss, Söhnke Kallen, Karl-Josef Fotin-Mleczek, Mariola Gnad-Vogt, Ulrike RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile |
| title | RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile |
| title_full | RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile |
| title_fullStr | RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile |
| title_full_unstemmed | RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile |
| title_short | RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile |
| title_sort | rnadjuvant(®), a novel, highly-potent rna-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645525/ http://dx.doi.org/10.1186/2051-1426-3-S2-P163 |
| work_keys_str_mv | AT heidenreichregina rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT mehrkeyvantadjalli rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT nothjanine rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT kochsven rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT honghenoch rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT melberkarl rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT daehlingangelika rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT roostilmann rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT lutzjohannes rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT kowalczykaleksandra rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT baumhofpatrick rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT scheelbirgit rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT vosssohnke rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT kallenkarljosef rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT fotinmleczekmariola rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile AT gnadvogtulrike rnadjuvantanovelhighlypotentrnabasedadjuvantcombinesstrongimmunostimulatorycapacitieswithafavorablesafetyprofile |